Diane Havlir
#110,928
Most Influential Person Now
US leader of HIV/AIDS work
Diane Havlir's AcademicInfluence.com Rankings
Diane Havlirphilosophy Degrees
Philosophy
#5504
World Rank
#8325
Historical Rank
Logic
#2772
World Rank
#3809
Historical Rank
Download Badge
Philosophy
Diane Havlir's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Diane Havlir Influential?
(Suggest an Edit or Addition)According to Wikipedia, Diane Havlir is an American physician who is a Professor of Medicine and Chief of the HIV/AIDS Division at the University of California, San Francisco. Her research considers novel therapeutic strategies to improve the lives of people with HIV and to support public health initiatives in East Africa. She was elected to the National Academy of Medicine in 2019.
Diane Havlir's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prevention of HIV-1 infection with early antiretroviral therapy. (2011) (2213)
- Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. (1997) (2126)
- Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. (1997) (1911)
- Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections (2002) (1736)
- The end of AIDS: HIV infection as a chronic disease (2013) (1455)
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission. (2016) (1154)
- Tuberculosis in patients with human immunodeficiency virus infection. (1999) (1060)
- HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function (2000) (1010)
- Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. (1999) (966)
- Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 (2020) (963)
- Class-sparing regimens for initial treatment of HIV-1 infection. (2008) (701)
- Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy (1994) (596)
- Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. (2011) (557)
- Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
- Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. (2014) (445)
- Prevalence and predictive value of intermittent viremia with combination hiv therapy. (2001) (395)
- Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. (1996) (332)
- Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. (2000) (317)
- Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. (1998) (316)
- High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. (1995) (313)
- Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. (2005) (312)
- Viral Dynamics of Acute HIV-1 Infection (1999) (303)
- In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues (1997) (293)
- Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. (2010) (282)
- Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. (1996) (278)
- Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment (2009) (261)
- Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: Intrinsic stability predicts lifelong persistence (2003) (259)
- Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. (1998) (255)
- Cryptosporidium infection and CD4 counts. (1992) (250)
- Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. (1997) (248)
- Sudden cardiac death in patients with human immunodeficiency virus infection. (2012) (242)
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy (2010) (242)
- Uganda Demographic and Health Survey 2016. Key indicators report. (2017) (239)
- Evolution of Envelope Sequences of Human Immunodeficiency Virus Type 1 in Cellular Reservoirs in the Setting of Potent Antiviral Therapy (1999) (221)
- Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort (2010) (218)
- Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy (1998) (217)
- Viral Dynamics of HIV: Implications for Drug Development and Therapeutic Strategies (1996) (215)
- Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients (1996) (204)
- 3-Year Suppression of HIV Viremia with Indinavir, Zidovudine, and Lamivudine (2000) (198)
- Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission (2018) (193)
- Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals (2007) (190)
- Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy. (2016) (170)
- Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. (2008) (168)
- Human immune response to Mycobacterium tuberculosis antigens (1991) (167)
- Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. (2006) (161)
- The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting (2017) (158)
- Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. (1998) (156)
- Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. (2000) (154)
- Productive Infection Maintains a Dynamic Steady State of Residual Viremia in Human Immunodeficiency Virus Type 1-Infected Persons Treated with Suppressive Antiretroviral Therapy for Five Years (2003) (154)
- The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. (2013) (152)
- HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. (2019) (151)
- Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. (2008) (151)
- Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. (2000) (145)
- Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. (2001) (145)
- Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. (2012) (144)
- Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors (2005) (142)
- Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. (2001) (140)
- Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. (2006) (137)
- Leveraging Rapid Community-Based HIV Testing Campaigns for Non-Communicable Diseases in Rural Uganda (2012) (131)
- Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. (1991) (131)
- Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa (2017) (122)
- Men “missing” from population-based HIV testing: insights from qualitative research (2016) (121)
- Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children (2014) (120)
- Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. (2007) (118)
- AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein. (2010) (105)
- Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children. (2012) (104)
- Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 (2021) (104)
- Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy (2000) (103)
- Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. (2016) (100)
- A hybrid mobile HIV testing approach for population-wide HIV testing in rural East Africa: an observational study (2016) (98)
- In vivo antagonism with zidovudine plus stavudine combination therapy. (2000) (97)
- Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. (1995) (94)
- The Effect of Expanded Antiretroviral Treatment Strategies on the HIV Epidemic among Men Who Have Sex with Men in San Francisco (2011) (92)
- Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco (2021) (91)
- “How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial (2016) (90)
- Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children (2007) (90)
- Virtual Inhibitory Quotient Predicts Response to Ritonavir Boosting of Indinavir-Based Therapy in Human Immunodeficiency Virus-Infected Patients with Ongoing Viremia (2002) (88)
- Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata. (2010) (88)
- Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers (2009) (83)
- Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE: Timing, Severity, and Implications for HIV–TB Programs (2014) (80)
- Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial (2014) (80)
- The case for earlier treatment of HIV infection. (2004) (79)
- Uptake of Community-Based HIV Testing during a Multi-Disease Health Campaign in Rural Uganda (2014) (78)
- Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature. (1990) (78)
- Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. (1999) (76)
- Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. (1998) (76)
- High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. (2008) (75)
- Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study (2018) (75)
- Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation (2016) (75)
- Atazanavir: new option for treatment of HIV infection. (2004) (74)
- A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group. (1997) (73)
- Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression (2001) (73)
- Comparative assessment of five trials of universal HIV testing and treatment in sub‐Saharan Africa (2018) (72)
- Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. (2016) (71)
- What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? (2020) (71)
- Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz. (2007) (71)
- Intensive care of patients with HIV infection. (2006) (69)
- Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. (2007) (69)
- The beginning of the end of AIDS? (2012) (68)
- Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine (2003) (68)
- Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda (2016) (66)
- Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. (2013) (66)
- A pilot study to evaluate the development of resistance to nevirapine in asymptomatic human immunodeficiency virus-infected patients with CD4 cell counts of > 500/mm3: AIDS Clinical Trials Group Protocol 208. (1995) (65)
- Autopsy findings in AIDS patients with Mycobacterium avium complex bacteremia. (1994) (65)
- Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011. (2012) (64)
- Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study (2020) (64)
- The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. (1994) (63)
- SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco (2020) (63)
- Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. (2009) (62)
- Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. (2005) (62)
- High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya (2017) (62)
- High levels of retention in care with streamlined care and universal test and treat in East Africa (2016) (61)
- Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study (2017) (60)
- Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study (2017) (60)
- A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells (2014) (59)
- RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. (2019) (59)
- HIV and tuberculosis – science and implementation to turn the tide and reduce deaths (2012) (59)
- HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children (2010) (59)
- 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (1999) (59)
- Nontuberculous mycobacteria in the HIV infected patient. (2002) (59)
- A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study. (2016) (59)
- Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study (2013) (58)
- Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19. (2020) (58)
- Zidovudine Compared With Didanosine in Patients With Advanced HIV Type I Infection and Little or No Previous Experience With Zidovudine (1995) (58)
- Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. (2000) (58)
- Uveitis Associated with Rifabutin Prophylaxis (1994) (57)
- Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. (2007) (56)
- Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women (2015) (56)
- Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial (2019) (56)
- Social, Structural and Behavioral Determinants of Overall Health Status in a Cohort of Homeless and Unstably Housed HIV-Infected Men (2012) (56)
- Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study (2019) (55)
- Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa (2012) (55)
- Evaluating linkage to care for hypertension after community‐based screening in rural Uganda (2014) (55)
- Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing (2020) (55)
- Hair and Plasma Data Show That Lopinavir, Ritonavir, and Efavirenz All Transfer From Mother to Infant In Utero, But Only Efavirenz Transfers via Breastfeeding (2013) (54)
- Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo (1996) (54)
- Impact of Antimalarial Treatment and Chemoprevention on the Drug Sensitivity of Malaria Parasites Isolated from Ugandan Children (2015) (54)
- Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients (2000) (54)
- Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance (2010) (54)
- Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy. (2001) (53)
- Treatment strategies for HIV-infected patients with tuberculosis: ongoing and planned clinical trials. (2007) (52)
- False-Positive Results of Enzyme Immunoassays for Human Immunodeficiency Virus in Patients with Uncomplicated Malaria (2006) (52)
- Vaccine-Induced Immune Responses in Rodents and Nonhuman Primates by Use of a Humanized Human Immunodeficiency Virus Type 1 pol Gene (2002) (51)
- Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention. (2007) (51)
- Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV-Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy (2012) (51)
- “Hurdles on the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat (2018) (50)
- Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study (2020) (49)
- Responding to organ failure in HIV-infected patients. (2003) (49)
- Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether–Lumefantrine in Healthy Volunteers (2012) (49)
- Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco (2020) (48)
- Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women (2015) (46)
- Complications of HIV disease and antiretroviral therapy. (2005) (46)
- Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy. (2001) (46)
- Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy (2014) (45)
- Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV‐infected pregnant and breastfeeding women in tororo, uganda (2014) (45)
- Sex differences in HIV RNA level and CD4 cell percentage during childhood. (2011) (45)
- Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria (2010) (44)
- Taking Vaccine to Where the Virus Is-Equity and Effectiveness in Coronavirus Vaccinations. (2021) (44)
- Degree of Housing Instability Shows Independent “Dose-Response” With Virologic Suppression Rates Among People Living With Human Immunodeficiency Virus (2018) (44)
- Metabolic Complications in HIV-1 Infection: Summary of Selected Trials (2002) (44)
- Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV (2017) (43)
- Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. (2018) (43)
- Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes (2017) (43)
- Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women. (2014) (42)
- Selective Expansion of Human 'yA T Cells by Monocytes Infected with Live Mycobacterium Tuberculosis (42)
- Evaluation of Two Line Probe Assays for Rapid Detection of Mycobacterium tuberculosis, Tuberculosis (TB) Drug Resistance, and Non-TB Mycobacteria in HIV-Infected Individuals with Suspected TB (2014) (41)
- Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study (2021) (41)
- New antiretrovirals and new combinations. (1998) (40)
- Distance to clinic is a barrier to PrEP uptake and visit attendance in a community in rural Uganda (2019) (40)
- Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. (2014) (40)
- Early Virologic Failure and the Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Ugandan Children (2011) (40)
- Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda (2009) (39)
- Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco (2020) (39)
- Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. (1996) (39)
- Tuberculosis as part of the natural history of HIV infection in developing countries. (2010) (38)
- Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa (2016) (38)
- Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya (2016) (36)
- Transient bacteremia due to Mycobacterium avium complex in patients with AIDS. (1994) (36)
- Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report. (2018) (36)
- Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis (2019) (36)
- Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. (2013) (35)
- Direct Comparison of SARS Co-V-2 Nasal RT- PCR and Rapid Antigen Test (BinaxNOWTM) at a Community Testing Site During an Omicron Surge (2022) (35)
- Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the “Getting to Zero” Era (2018) (35)
- Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda (2013) (34)
- Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines (2020) (34)
- Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/&mgr;l in rural Uganda (2014) (34)
- Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. (2008) (34)
- Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression (2002) (33)
- Baseline Predictors of CD4 T‐Lymphocyte Recovery With Combination Antiretroviral Therapy (2002) (33)
- Antiretroviral Therapy With Efavirenz Accentuates Pregnancy‐Associated Reduction of Dihydroartemisinin‐Piperaquine Exposure During Malaria Chemoprevention (2017) (33)
- Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial (1999) (32)
- Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. (2008) (32)
- Profile of T cell immune responses in HIV-infected children from Uganda. (2007) (32)
- High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in Uganda. (2013) (32)
- Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations (2020) (32)
- A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice (2021) (32)
- Complications of HIV disease and antiretroviral therapy. (2009) (32)
- Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach (2015) (31)
- Household Food Insecurity, Maternal Nutritional Status, and Infant Feeding Practices Among HIV-infected Ugandan Women Receiving Combination Antiretroviral Therapy (2014) (31)
- Site-Specific Differences in T Cell Frequencies and Phenotypes in the Blood and Gut of HIV-Uninfected and ART-Treated HIV+ Adults (2015) (31)
- Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda. (2019) (31)
- Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda (2018) (31)
- Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda (2017) (30)
- Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study. (2015) (30)
- Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda (2016) (30)
- The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting. (2012) (30)
- Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection (2011) (29)
- A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086. (2006) (29)
- No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant (2021) (29)
- Reproducibility of lysis-centrifugation cultures for quantification of Mycobacterium avium complex bacteremia (1993) (28)
- Serum Interleukin-6 (IL-6), IL-10, Tumor Necrosis Factor (TNF) Alpha, Soluble Type II TNF Receptor, and Transforming Growth Factor Beta Levels in Human Immunodeficiency Virus Type 1-Infected Individuals with Mycobacterium avium Complex Disease (2001) (28)
- Virologic and Immunologic Outcomes of HIV-Infected Ugandan Children Randomized to Lopinavir/Ritonavir or Nonnucleoside Reverse Transcriptase Inhibitor Therapy (2014) (27)
- HIV integrase inhibitors--out of the pipeline and into the clinic. (2008) (27)
- Getting to Zero San Francisco: A Collective Impact Approach. (2019) (27)
- Complications of HIV disease and antiretroviral therapy. (2005) (27)
- Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. (2014) (27)
- Gendered dimensions of population mobility associated with HIV across three epidemics in rural Eastern Africa. (2019) (27)
- Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria (2013) (26)
- HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. (2021) (26)
- Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women (2017) (25)
- Complications of HIV infection and antiretroviral therapy. (2003) (25)
- Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco (2021) (25)
- Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation (2016) (25)
- Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda (2016) (25)
- The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda. (2009) (25)
- Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial (2014) (25)
- Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication (2000) (25)
- Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco (2021) (24)
- The Effect of Malnutrition on the Pharmacokinetics and Virologic Outcomes of Lopinavir, Efavirenz and Nevirapine in Food Insecure HIV-infected Children in Tororo, Uganda (2015) (24)
- Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. (2009) (24)
- Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial. (2019) (24)
- Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19 (2021) (24)
- Impact of Intermittent Preventive Treatment During Pregnancy on Plasmodium falciparum Drug Resistance–Mediating Polymorphisms in Uganda (2017) (24)
- Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda (2007) (24)
- Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge (2022) (23)
- Complications of HIV disease and antiretroviral therapy. (2011) (22)
- Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. (2010) (22)
- Tuberculosis Treatment in HIV Infected Ugandans with CD4 Counts >350 Cells/mm3 Reduces Immune Activation with No Effect on HIV Load or CD4 Count (2010) (22)
- SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco (2020) (22)
- Structured intermittent treatment for HIV disease: Necessary concession or premature compromise? (2002) (22)
- Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a U.S. City. (2019) (22)
- Implementation challenges for long-acting antivirals as treatment (2015) (21)
- Population Levels and Geographic Distribution of HIV RNA in Rural Ugandan and Kenyan Communities and Sero-Discordant Couples: a Cross-Sectional Analysis (2016) (21)
- A 19-year follow-up of tuberculin reactors. Assessment of skin test reactivity and in vitro lymphocyte responses. (1991) (21)
- Comparative effectiveness of novel nonmonetary incentives to promote HIV testing (2018) (21)
- The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now (2020) (20)
- Patient and provider perceptions of a comprehensive care program for HIV-positive adults over 50 years of age: The formation of the Golden Compass HIV and aging care program in San Francisco (2018) (20)
- A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. (2011) (20)
- Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. (2011) (20)
- The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study (2020) (20)
- Patents versus patients? Antiretroviral therapy in India. (2005) (20)
- Newer nucleosides: lamivudine and stavudine (1996) (19)
- Sustainable East Africa Research in Community Health (SEARCH): a community cluster randomized study of HIV "test and treat" using multi-disease approach in rural Uganda and Kenya (2017) (19)
- Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma. (1999) (18)
- High-Dose Lopinavir/Ritonavir in Highly Treatment-Experienced HIV-1 Patients: Efficacy, Safety, and Predictors of Response (2007) (18)
- Brief Report: Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women (2016) (18)
- RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population. (2019) (18)
- The science of rapid start—From the when to the how of antiretroviral initiation (2017) (18)
- Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial (2018) (18)
- Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine (2018) (18)
- Monthly Sulfadoxine–Pyrimethamine Versus Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria in Pregnancy: A Double-blind, Randomised, Controlled, Superiority Trial (2019) (18)
- To stop or not to stop: that is the question, but what is the answer? (2002) (17)
- SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron (2022) (17)
- Gaps in the child tuberculosis care cascade in 32 rural communities in Uganda and Kenya (2017) (17)
- Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus. (1998) (17)
- Changes in Population HIV RNA Levels in Mbarara, Uganda, During Scale-up of HIV Antiretroviral Therapy Access (2014) (17)
- Predictors of Retention in HIV Care Among Youth (15–24) in a Universal Test-and-Treat Setting in Rural Kenya (2017) (17)
- Evaluating the feasibility and uptake of a community-led HIV testing and multi-disease health campaign in rural Uganda (2017) (17)
- Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells (2016) (17)
- Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. (2019) (17)
- Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys (2018) (17)
- A pilot metabolomics study of tuberculosis immune reconstitution inflammatory syndrome (2019) (17)
- Evaluation of a novel community-based COVID-19 'Test-to-Care model' for low-income populations (2020) (16)
- The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa. (2012) (16)
- Tuberculosis drug development: ensuring people living with HIV are not left behind. (2011) (16)
- Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda. (2016) (15)
- Complications of HIV disease and antiretroviral treatment. (2010) (15)
- Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda (2015) (15)
- "A bird in the hand...": a commentary on the test and treat approach for HIV. (2010) (15)
- Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz (2018) (14)
- A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya. (2019) (14)
- Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children. (2014) (14)
- Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies. (1989) (14)
- Rapid increase in tuberculosis incidence soon after infection with HIV--a new twist in the twin epidemics. (2005) (14)
- Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry (2017) (14)
- Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial (2020) (14)
- Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy (2010) (13)
- The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action (2021) (13)
- Redemption of the “spoiled identity:” the role of HIV‐positive individuals in HIV care cascade interventions (2017) (13)
- The impact of gravidity, symptomatology and timing of infection on placental malaria (2020) (13)
- Sex Disparity in Cord Blood FoxP3+ CD4 T Regulatory Cells in Infants Exposed to Malaria In Utero (2017) (12)
- Antiretroviral therapy and TB (2006) (12)
- Confronting TB/HIV in the era of increasing anti-TB drug resistance (2008) (12)
- Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda (2018) (12)
- Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. (2013) (12)
- Dimensions of HIV-related stigma in rural communities in Kenya and Uganda at the start of a large HIV ‘test and treat’ trial (2021) (12)
- Housing Instability Results in Increased Acute Care Utilization in an Urban HIV Clinic Cohort (2019) (12)
- The Impact of Control Interventions on Malaria Burden in Young Children in a Historically High-Transmission District of Uganda: A Pooled Analysis of Cohort Studies from 2007 to 2018 (2020) (12)
- Household ventilation and tuberculosis transmission in Kampala, Uganda. (2013) (12)
- Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda. (2012) (11)
- Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda (2019) (11)
- Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant (2022) (11)
- Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda (2018) (11)
- Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count. (2010) (11)
- A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya (2018) (11)
- Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study. (2018) (11)
- Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. (2008) (10)
- The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation. (2011) (10)
- Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. (2009) (10)
- Human Immunodeficiency Virus Replication in AIDS Patients with Mycobacterium avium Complex Bacteremia: A Case Control Study (1998) (10)
- Assessing the Quality of Tuberculosis Evaluation for Children with Prolonged Cough Presenting to Routine Community Health Care Settings in Rural Uganda (2014) (10)
- CROI 2015: Complications of HIV Infection and Antiretroviral Therapy. (2015) (10)
- Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. (2019) (10)
- Improving Care Outcomes for PLWH Experiencing Homelessness and Unstable Housing: a Synthetic Review of Clinic-Based Strategies (2020) (10)
- Viral suppression during COVID-19 among people with HIV experiencing homelessness in a low-barrier clinic-based program (2020) (10)
- The Golden Compass Program: Overview of the Initial Implementation of a Comprehensive Program for Older Adults Living with HIV (2020) (10)
- Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. (2011) (10)
- Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials (2021) (9)
- Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. (1999) (9)
- Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial (2021) (9)
- Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial. (2019) (9)
- Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic (2011) (9)
- Expectations about future health and longevity in Kenyan and Ugandan communities receiving a universal test-and-treat intervention in the SEARCH trial (2016) (9)
- HIV RNA suppression among HIV-infected Ugandan children with measles. (2008) (9)
- Aberrant and Unstable Expression of Immunoglobulin Genes in Persons Infected With Human Immunodeficiency Virus (1998) (9)
- Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy (2016) (9)
- Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. (2020) (9)
- Neonatal mortality in HIV-exposed infants born to women receiving combination antiretroviral therapy in Rural Uganda. (2013) (9)
- CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. (2017) (8)
- First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic (2022) (8)
- Statistical Analysis Plan for SEARCH Phase I: Health Outcomes among Adults. (2018) (8)
- Men’s Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda (2020) (8)
- Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells (2018) (8)
- Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. (2004) (8)
- “I Have Remained Strong Because of That Food”: Acceptability and Use of Lipid-Based Nutrient Supplements Among Pregnant HIV-Infected Ugandan Women Receiving Combination Antiretroviral Therapy (2015) (8)
- The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda (2020) (8)
- HIV-1 Infection in Patients Referred for Malaria Blood Smears at Government Health Clinics in Uganda (2007) (8)
- SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV (2021) (8)
- Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda (2020) (7)
- Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa: a simulation study. (2020) (7)
- Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study (2022) (7)
- A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). (2002) (7)
- Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation (2020) (7)
- Cost and efficiency of a hybrid mobile multi-disease testing approach with high HIV testing coverage in East Africa. (2016) (7)
- A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda (2020) (7)
- Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. (2008) (7)
- SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron (2021) (7)
- Global HIV Treatment - Turning Headwinds to Tailwinds. (2019) (7)
- Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV–Coinfected Adults With Persistent HBV Viremia (2011) (7)
- Acceptability and feasibility of serial HIV antibody testing during pregnancy/postpartum and male partner testing in Tororo, Uganda (2014) (7)
- Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation analysis (2020) (7)
- Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community (2020) (7)
- Mobile, Population-wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda (2018) (7)
- CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. (2018) (6)
- Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda (2021) (6)
- Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis (2017) (6)
- Overcoming the human immunodeficiency virus obstacle course. (2013) (6)
- Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing. (2021) (6)
- Far from MCAR: obtaining population-level estimates of HIV viral suppression (2019) (6)
- Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole (2019) (6)
- The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society. (2002) (6)
- CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy. (2013) (5)
- Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care (2017) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya (2019) (5)
- COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods (2022) (5)
- Complications of HIV disease and therapy. (2007) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Planning prompts to promote uptake of HIV services among men: a randomised trial in rural Uganda (2020) (5)
- Ending AIDS in the United States-If Not Now, When? (2019) (5)
- CROI 2019: complications and coinfections in HIV infection. (2019) (5)
- Coadministration of Indinavir and Nelfinavir in Human Immunodeficiency Virus Type 1-Infected Adults: Safety, Pharmacokinetics, and Antiretroviral Activity (2002) (5)
- The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda. (2020) (5)
- Effect of a Patient-Centered Phone Call by a Clinical Officer at Time of HIV Testing on Linkage to Care in Rural Kenya (2018) (5)
- Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda (2021) (5)
- SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures (2020) (5)
- Pragmatic randomized trial of a pre-visit intervention to improve the quality of telemedicine visits for vulnerable patients living with HIV (2020) (5)
- High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial (2018) (5)
- Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study (2020) (5)
- Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage Among San Francisco Men Who Have Sex With Men (2021) (5)
- Gravidity-dependent associations between interferon response and birth weight in placental malaria (2016) (5)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Putting women in the centre of the global HIV response is key to achieving epidemic control! (2020) (4)
- Eff ects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection : results from the phase 3 HPTN 052 randomised controlled trial (2014) (4)
- Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community (2020) (4)
- Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda (2016) (4)
- Generation of a malaria negative Ugandan birth weight standard for the diagnosis of small for gestational age (2020) (4)
- Exposures to different SARS-CoV-2 spike variants elicit neutralizing antibody responses with differential specificity towards established and emerging strains (2021) (4)
- Infant sex modifies associations between placental malaria and risk of malaria in infancy (2020) (4)
- High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco (2021) (4)
- CD4+ T cell reconstitution, T cell activation, and memory T cell subset composition in blood and gut of HIV-negative and ART-suppressed HIV-positive patients: implications for HIV persistence in the gut (2010) (4)
- An earlier start for HIV therapy (2009) (4)
- Anemia and Micronutrient Status during Pregnancy, and Their Associations with Obstetric and Infant Outcomes among HIV-Infected Ugandan Women Receiving Antiretroviral Therapy (2020) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Breastfeeding practices and beliefs among HIV+ pregnant and lactating women on antiretroviral therapy in rural Uganda indicate obstacles to following national guidelines (2012) (3)
- CROI 2016: Complications of HIV Infection and Antiretroviral Therapy. (2016) (3)
- SARS-CoV-2 vaccine boosters: The time to act is now (2021) (3)
- Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women (2020) (3)
- Reaching 90–90–90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial (2019) (3)
- Costs of integrating hypertension care into HIV care in rural East African clinics (2021) (3)
- CROI 2021: Tuberculosis, Opportunistic Infections, and COVID-19 Among People with HIV. (2021) (3)
- “I was still very young”: agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda (2022) (3)
- SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts. (2021) (3)
- Viral suppression not decreased during COVID-19 among people with HIV and unstable housing enrolled in a low-barrier clinic-based program (POP-UP). (2020) (3)
- Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. (2023) (3)
- Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment. (2020) (3)
- Understanding preferences for HIV care among patients experiencing homelessness or unstable-housing: A discrete choice experiment. (2020) (3)
- 1298. Acquisition of TDF-Susceptible HIV Despite High Level Adherence to Daily TDF/FTC PrEP as Measured by Dried Blood Spot (DBS) and Segmental Hair Analysis: A Case Report (2018) (3)
- Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya (2021) (3)
- The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy (2004) (3)
- Mycobacterium avium complex: Advances in therapy (1994) (3)
- Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS. (2013) (3)
- Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. (2021) (3)
- Prophylaxis and treatment of malaria in HIV-infected populations (2008) (3)
- HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness. (2022) (3)
- Pathways to care and preferences for improving tuberculosis services among tuberculosis patients in Zambia: A discrete choice experiment (2021) (3)
- A 32-year-old man with the acquired immunodeficiency syndrome and pneumococcal meningitis. (1987) (2)
- Examining the Impact of the Golden Compass Clinical Care Program for Older People with HIV: A Qualitative Study (2021) (2)
- Effect of malaria and malaria chemoprevention regimens in pregnancy and childhood on neurodevelopmental and behavioral outcomes in children at 12, 24 and 36 months: a randomized clinical trial. (2022) (2)
- Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda. (2022) (2)
- Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study (2021) (2)
- Provider and Patient Perspectives of Rapid ART Initiation and Streamlined HIV Care: Qualitative Insights From Eastern African Communities (2021) (2)
- SecA1 PCR on Sputum or Oral Wash for the Diagnosis of Pulmonary Tuberculosis * (2009) (2)
- Paradigm shift to address drug resistant tuberculosis in people living with HIV needed, and needed now (2009) (2)
- Transmission of Multi-drug-Resistant HIV (1998) (2)
- WHO option B+: early experience of antiretroviral therapy sequencing after cessation of breastfeeding and risk of dermatologic toxicity. (2013) (2)
- Social Networks and HIV Care Outcomes in Rural Kenya and Uganda (2021) (2)
- Far from MCAR (2020) (2)
- Semi-Supervised Record Linkage for Construction of Large-Scale Sociocentric Networks in Resource-limited Settings: An application to the SEARCH Study in Rural Uganda and Kenya (2019) (2)
- Human immunodeficiency virus replication in AIDS patients with Mycobacterium avium complex bacteremia: a case control study. California Collaborative Treatment Group. (1998) (2)
- Effect of universal HIV testing and treatment on socioeconomic wellbeing in rural Kenya and Uganda: a cluster-randomised controlled trial (2022) (2)
- Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial. (2020) (2)
- Patient Preferences for Strategies to Improve Tuberculosis Diagnostic Services in Zambia (2022) (1)
- Erratum: The case for earlier treatment of HIV infection (Clinical Infections Diseases (December 1, 2004) 39 (1699-1704)) (2004) (1)
- Adding two new drug classes improves outcome in salvage therapy. (2001) (1)
- A Paradox Confirmed: GB Virus C and HIV Disease Progression (2004) (1)
- Track A Basic Science (2012) (1)
- CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy. (2014) (1)
- SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures (2021) (1)
- Same‐day test and treat for infants with HIV infection: finally within reach (2022) (1)
- Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge (2022) (1)
- Strategic approaches to antiretroviral treatment. (2003) (1)
- Population HIV viral load metrics for community health. (2021) (1)
- Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop. (1995) (1)
- A mid-level health manager intervention to promote uptake of isoniazid preventive therapy among people with HIV in Uganda: a cluster randomised trial (2022) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- LEFT VENTRICULAR DYSFUNCTION PREDICTS SUDDEN CARDIAC DEATH IN A LARGE HIV-POSITIVE COHORT (2012) (1)
- PEP for HIV prevention: are we missing opportunities to reduce new infections? (2022) (1)
- HIV retesting and risk behaviors among high-risk, HIV-uninfected adults in Uganda (2020) (1)
- Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates During Covid-19: An Interrupted Time Series Analysis (2021) (1)
- Track D Social Science, Human Rights and Political Science (2012) (1)
- Screening for Covid-19 in Skilled Nursing Facilities. Reply. (2020) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- Track E Implementation Science, Health Systems and Economics (2012) (1)
- PR Interval and sudden cardiac death in patients with HIV infection. (2013) (1)
- Closing the gap: A novel metric of change in performance. (2019) (1)
- COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022 (2022) (1)
- Top Stories in HIV Medicine (2009) (1)
- Biochemical and clinical aspects of amyloidosis. (1987) (1)
- Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program (2022) (1)
- Two or more significant life-events in 6-months are associated with lower rates of HIV treatment and virologic suppression among youth with HIV in Uganda and Kenya (2022) (1)
- Improved Viral Suppression With Streamlined Care in the SEARCH Study (2020) (1)
- Typhoid Fever (1919) (0)
- Relationships between infection with Plasmodium falciparum during pregnancy, measures of placental malaria, and adverse birth outcomes (2017) (0)
- pilot metabolomics study of immune reconstitution inflammatory syndrome. (2019) (0)
- Oral Induction Therapy for CMV Retinitis, at Last (2002) (0)
- Statistical Analysis Plan for Primary and Selected Secondary Health Endpoints of the SEARCH-Youth Study (2022) (0)
- Formula Feeding Reduces HIV Transmission in Kenya (2000) (0)
- Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial (2022) (0)
- CMV Infection Associated with Worse Prognosis in HIV-Infected Children (1999) (0)
- CROI 2022: tuberculosis and infectious complications in persons With HIV. (2022) (0)
- Impact of Multicomponent Support Strategies on Human Immunodeficiency Virus Virologic Suppression Rates During Coronavirus Disease 2019: An Interrupted Time Series Analysis (2022) (0)
- Detection of HIV-1 Transmission Clusters from Dried Blood Spots within a Universal Test-and-Treat Trial in East Africa (2022) (0)
- Simplifying HIV Therapy: History Counts (2003) (0)
- Oral Ganciclovir for Cytomegalovirus Disease Prophylaxis (1998) (0)
- Reply to Wilson et al (2011) (0)
- Cesarean Delivery for Prevention of HIV Transmission (1998) (0)
- Cidofovir for Relapsing CMV Retinitis (1998) (0)
- Virtual CROI 2020: Tuberculosis and Coinfections In HIV Infection. (2020) (0)
- 737: Acceptability of serial HIV testing and partner testing during pregnancy and lactation in Tororo, Uganda (2012) (0)
- When to Start Antiretroviral Therapy -- Additional Insights (2001) (0)
- Simplifying HIV Therapy (2001) (0)
- Department of Medicine, University of California, San Francisco (2015) (0)
- Track B Clinical Science (2012) (0)
- Track B Clinical Science (2012) (0)
- Candida Cross Resistance to Azoles (1998) (0)
- Predictive Value of HIV RNA Level and CD4+ Cell Count in Pediatric HIV Disease (1998) (0)
- Drug-Resistant HIV -- Persistent from the Start (2004) (0)
- Population-based active TB case finding during large-scale mobile HIV testing campaigns in rural Uganda. (2016) (0)
- Echinacea Extract Doesn't Prevent Colds (1999) (0)
- Nutritional status of the elderly in Palmares, Costa Rica. (1983) (0)
- Cidofovir May Improve Outcome of AIDS Patients with PML (2000) (0)
- The impact of gravidity, symptomatology and timing of infection on placental malaria (2020) (0)
- HIV post-treatment controllers have distinct immunological and virological features. (2023) (0)
- Progress in HIV care outcomes among Black men in San Francisco. (2021) (0)
- antiviral agent that may be used in combination with antiretroviral therapy. (2015) (0)
- Clinical Management of HIV Infection (2004) (0)
- Gravidity-dependent associations between interferon response and birth weight in placental malaria (2020) (0)
- HIV and Malaria: Double Trouble During Pregnancy (2003) (0)
- Intermittent IL-2 Plus Potent Antiretroviral Therapy (2000) (0)
- Sustained HIV Suppression with Nevirapine Combination (1998) (0)
- Secondary Pneumocystis carinii Prophylaxis Safely Stopped (2001) (0)
- Drug-Resistant HIV Virus in Newly Infected Individuals (1999) (0)
- Does PCR Improve Management of Herpes Simplex Encephalitis (1998) (0)
- Antiretroviral Therapy in Infants: Earlier Is Better (2004) (0)
- CCR5 Mutations in Children of HIV-infected Mothers (1998) (0)
- Overlapping Incidence Rates for Diabetes Among Patients on Their First Antiretroviral Therapy Regimen (0)
- Maintenance Antiretroviral Therapy Insufficient to Sustain HIV Suppression (1998) (0)
- Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges (2022) (0)
- Reductions in malaria in pregnancy and adverse birth outcomes following indoor residual spraying of insecticide in Uganda (2016) (0)
- Structured intermittent treat Necessary concession or prel (2016) (0)
- Systemic inflammation is associated with malaria and preterm birth in women living with HIV on antiretrovirals and co-trimoxazole (2019) (0)
- Brief Report: Heterogeneous Preferences for Care Engagement Among People With HIV Experiencing Homelessness or Unstable Housing During the COVID-19 Pandemic (2022) (0)
- Closing the gap: (2019) (0)
- Overview of Hepatitis C Virus Direct-Acting Antiviral Drugs : Present and Future (2014) (0)
- Complications of HIV disease and antiretroviral therapy. (2009) (0)
- Refining the Choices for Initial HIV Therapy (2004) (0)
- 633: Generation of a malaria-negative African birthweight standard for diagnosis of small for gestational age (2020) (0)
- Achieving the UNAIDS 90–90-90 targets: a comparative analysis of four large community randomised trials delivering universal testing and treatment to reduce HIV transmission in sub-Saharan Africa (2022) (0)
- Insights into Initial HIV Therapy (2004) (0)
- Transmission and fitness of drug resistant strains of HIV (2000) (0)
- The Association Between Social Network Characteristics and Tuberculosis Infection Among Adults in Nine Rural Ugandan Communities. (2022) (0)
- Residual HIV Replication Despite Potent Antiretroviral Therapy: More Evidence (2000) (0)
- 448. Disproportionate Burden of COVID-19 on Latinx Residents among Hospitalized Patients at San Francisco’s Public Health Hospital (2020) (0)
- Timing of in utero malaria exposure influences fetal CD4 T cell regulatory versus effector differentiation (2016) (0)
- HIV Immunogen Fails to Improve Outcome (2000) (0)
- PROLONGED QT INTERVAL PREDICTS SUDDEN CARDIAC DEATH IN HIV-INFECTED INDIVIDUALS (2013) (0)
- Morbidity and Mortality in the Potent Antiretroviral Therapy Era (2008) (0)
- First-Line Therapy for HIV Disease: Efavirenz (2000) (0)
- Preliminary safety and activity evaluation of new agents for the treatment of HIV-1 infection: Recommended guidelines for trial design (1992) (0)
- Anemia, vitamin B12, and folate statuses during pregnancy, and their association with obstetric outcomes among HIV‐infected Ugandan women receiving ART (804.8) (2014) (0)
- Drug-Resistance Testing Beneficial in HIV Salvage Therapy (2000) (0)
- Is Hypersusceptibility to NNRTIs Clinically Significant (2002) (0)
- Feasibility and preliminary effectiveness of integrating HIV prevention into an adolescent empowerment and livelihood intervention at youth clubs in rural Uganda (2022) (0)
- HIV Prevention: Nonoxynol-9 Gel Is Not the Solution (2002) (0)
- Reply to DiNubile (2008) (0)
- HIV Care Less Expensive Than Believed (1999) (0)
- Nevirapine: A Viewpoint by Diane Havlir (1996) (0)
- Does Awareness of HIV PEP Increase High-Risk Sexual Behavior? (2000) (0)
- Reproducibility and implementation of a rapid, community-based COVID-19 “test and respond” model in low-income, majority-Latino communities in Northern California (2022) (0)
- Selected Highlights of the 2021 virtual Conference on Retroviruses and Opportunistic Infections ( Part I ) CME CROI 2021 : Epidemiologic Trends in the HIV and SARS-CoV-2 Pandemics and HIV Prevention Research 309 (2021) (0)
- Infant sex modifies associations between placental malaria and risk of malaria in infancy (2020) (0)
- Intriguing Differences in Lipid Effects Between Efavirenz and Nevirapine (2004) (0)
- HIV Co-Infection -- The Evidence Accumulates (2004) (0)
- HIV and the Global Pandemic Convener (2008) (0)
- Early Versus Delayed Treatment of HIV Infection (2012) (0)
- Potent Antiretroviral Therapy Does Not Eliminate HIV from Semen (1999) (0)
- SKEWED AND UNSTABLE B-CELL REPERTOIRE IN SERIAL BLOOD SAMPLES OF HIV INFECTED PATIENTS. POTENTIAL ROLE IN THE INDUCTION OF AIDS-ASSOCIATED LYMPHOMA: 138 (1997) (0)
- Alternative Zidovudine Doses Reduce HIV Perinatal Transmission (2000) (0)
- HIV Lipodystrophy Syndrome: A Novel Approach to Treatment (2000) (0)
- Report on HIV/TB Research meeting in conjunction with the 2019 CROI Conference on Retroviruses and Opportunistic Infections (2019) (0)
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons (2022) (0)
- Weight change following switch to dolutegravir for HIV treatment in rural Kenya during country roll-out. (2023) (0)
- Guidelines for HIV Resistance Testing (2000) (0)
- Acquisition of tenofovir-susceptible HIV despite consistently high level adherence to daily PrEP as measured by plasma, dried blood spot (DBS) and segmental hair analysis: a case report (2019) (0)
- Clinical Management of the Immune Reconstitution Syndrome (2004) (0)
- Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting (2016) (0)
- Hydroxyurea's Efficacy in HIV Disease (1998) (0)
- Intermittent preventive treatment with dihydroartemisinin-piperaquine in young Ugandan children and risk of malaria following cessation: A randomised controlled trial (2019) (0)
- Indinavir-Associated Lipodystrophy (1998) (0)
- Filgrastim to Treat HIV Neutropenia (1998) (0)
- CMV Viremia Predicts CMV Retinitis (1999) (0)
- Kaposi's Sarcoma Response to Antiretroviral Therapy (1998) (0)
- Greater HIV Suppression Improves Treatment Response (1998) (0)
- The Impact of Control Interventions on Malaria Burden in a Historically High Transmission District of Uganda: A Pooled Analyses of Cohort Studies from 2007 to 2018 (2019) (0)
- Is Lipodystrophy Reversible in HIV-Positive Patients? (2001) (0)
- Low Plasma Levels of Protease Inhibitors Predict Poor Response (2000) (0)
- Lower Viral Load, Less HIV Transmission (2000) (0)
- Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting (2016) (0)
- Statistical Analysis Plan for Health Outcomes in Phase 1 of the SEARCH-IPT Study (2021) (0)
- Brief Treatment Interruptions for HIV Infection (2001) (0)
- New HIV Drug: Abacavir (1999) (0)
- High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community (2021) (0)
- Single-Dose Nevirapine Reduces Perinatal Transmission of HIV (1999) (0)
- A Vitamin a Day to Keep HIV at Bay (2004) (0)
- A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants (2022) (0)
This paper list is powered by the following services:
Other Resources About Diane Havlir
What Schools Are Affiliated With Diane Havlir?
Diane Havlir is affiliated with the following schools:
